Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The Amyloid precursor protein (APP) processing pathway, also known as the Aβ-related enzymes and processing axis, is a complex proteolytic system that regulates the production and degradation of amyloid-beta (Aβ) peptides. This axis involves the competing activities of α-secretase (ADAM10), which initiates the non-amyloidogenic pathway, and β-secretase (BACE1) followed by γ-secretase, which drive the amyloidogenic production of neurotoxic Aβ species. The balance of this axis is further maintained by Aβ-degrading enzymes such as neprilysin and insulin-degrading enzyme, which clear Aβ from the brain. Dysregulation of this processing axis is a central driver of Alzheimer's disease pathology, leading to the accumulation of Aβ plaques and subsequent neurodegeneration. Therapeutic strategies targeting this axis have primarily focused on BACE1 and γ-secretase inhibition, though these have faced significant clinical hurdles due to off-target effects and safety concerns. Recent research also explores the activation of α-secretase and the enhancement of degrading enzymes to restore Aβ homeostasis.
Modulation of the proteolytic cleavage of amyloid precursor protein (APP) by inhibiting β-secretase (BACE1) or γ-secretase to reduce Aβ production, or by activating α-secretase (ADAM10) to promote the non-amyloidogenic pathway. It also includes the clearance of Aβ products via enzymatic degradation or antibody-mediated removal.
10 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Amyloid precursor protein processing pathway (APP processing pathway).